Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dye-induced nephropathy.

Samuel N Heyman1, Seymour Rosen

  • 1Department of Medicine, Hadassah University Hospital, Mt. Scopus, Jerusalem 91240, Israel. heyman@cc.huji.ac.il

Seminars in Nephrology
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detected residual venous thrombi and catheter-directed management of intermediate-risk pulmonary thromboembolism.

Frontiers in cardiovascular medicine·2026
Same author

Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant.

Kidney international reports·2026
Same author

The Impact of Sodium Glucose Transporter 2 Inhibitors on Renal Parenchymal Oxygenation: An Unsettled Issue?

Kidney360·2026
Same author

Amino acid infusion and SGLT2 inhibitors for kidney protection: Plausible adverse impact of tubular transport load on renal tissue oxygenation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.

The New England journal of medicine·2026
Same author

Sclerosing Cholangitis and Multiple Liver Abscesses in a Patient with Thymoma, Myasthenia Gravis, and Immune Deficiency (Good's Syndrome).

The American journal of case reports·2025
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Radiologic contrast agents can cause kidney damage, known as dye nephropathy, a major cause of acute kidney failure in ICUs. This review details its causes, risks, and prevention strategies.

Area of Science:

  • Nephrology
  • Radiology
  • Pharmacology

Background:

  • Iodinated radiologic contrast agents are widely used in medical imaging and interventional procedures.
  • Dye nephropathy, or contrast-induced nephropathy, is a significant cause of iatrogenic acute kidney injury.
  • It accounts for approximately 10% of acute renal failure cases in intensive care units.

Purpose of the Study:

  • To review the pathophysiology of radiocontrast nephropathy.
  • To emphasize the role of medullary hypoxic damage in contrast-induced nephropathy.
  • To discuss risk factors, clinical course, prevention, and potential therapeutic interventions.

Main Methods:

  • Literature review of radiocontrast nephropathy.
  • Analysis of pathophysiological mechanisms, focusing on medullary hypoxia.

Related Experiment Videos

  • Synthesis of information on risk factors, clinical presentation, and management strategies.

    • Main Results:

    • Radiocontrast agents pose a risk for nephropathy, particularly with expanding use.
    • Medullary hypoxic damage is a key factor in the pathophysiology of dye nephropathy.
    • Risk factors, clinical course, and preventive measures are critical for patient outcomes.

    Conclusions:

    • Understanding the pathophysiology, especially medullary hypoxia, is crucial for managing contrast-induced nephropathy.
    • Identifying and mitigating risk factors are essential for preventing acute kidney injury.
    • Further research into therapeutic interventions may improve outcomes for patients at risk.